United Kingdom - English - VMD (Veterinary Medicines Directorate)

ceva animal health ltd - clostridium perfringens, escherichia coli - lyophilisate and solvent for suspension for injection - inactivated bacterial vaccine - pigs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

laboratorios hipra sa - clostridium novyi, clostridium perfringens, escherichia coli - suspension for injection - inactivated bacterial vaccine - pigs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

laboratorios hipra sa - clostridium novyi, clostridium perfringens, escherichia coli - suspension for injection - inactivated bacterial vaccine - pigs

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratorios hipra s.a. - f4ab fimbrial adhesin of e.coli, f4ac fimbrial adhesin of e.coli, f5 fimbrial adhesin of e.coli, f6 fimbrial adhesin of e. coli, lt enterotoxoid of e. coli, clostridium perfringens type c toxoid, clostridium novyi type b toxoid - suspension for injection - unknown - escherichia vaccine + clostridium vaccine - porcine - immunological - inactivated vaccine

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 100 u - muscle relaxants

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 50 u - muscle relaxants

European Union - English - EMA (European Medicines Agency)

intervet international bv - clostridium-perfringens-type-a alpha toxoid - immunologicals for aves - chicken - for the active immunisation of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.to reduce mortality and the incidence and severity of lesions caused by clostridium-perfringens-type-a-induced necrotic enteritis. efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.the onset of passive transfer of immunity: 6 weeks following completion of the vaccination procedure.the duration of passive transfer of immunity: 51 weeks following completion of the vaccination procedure.

New Zealand - English - Ministry for Primary Industries

schering-plough animal health limited - clostridium septicum toxoid; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium novyi type b toxoid/cells; clostridium chauvoei toxoid/cells - clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - vaccine

European Union - English - EMA (European Medicines Agency)

laboratorios hipra, s.a. - recombinant verotoxin 2e of e. coli - inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium, immunologicals for suidae - pigs - active immunisation of piglets from 2 days of age to prevent mortality and reduce clinical signs of oedema disease (caused by verotoxin 2e produced by e. coli) and to reduce the loss of daily weight gain during the finishing period in the face of infections with verotoxin 2e producing e. coli until slaughter from 164 days of age.

Malta - English - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - clostridium botulinum, toxin type, a - powder for solution for injection - clostridium botulinum toxin type a 200 u - muscle relaxants